Lipid-lowering therapy with pravastatin reduces coronary plaque volume: Role of high-density lipoprotein cholesterol containing apolipoprotein A-1

被引：0
|
作者：
Tani, S [1 ]
Watanabe, I [1 ]
Oguchi, S [1 ]
Anazawa, T [1 ]
Takahashi, H [1 ]
Nomoto, K [1 ]
Miya, N [1 ]
Ishikawa, K [1 ]
Matsumoto, M [1 ]
Nosaka, T [1 ]
Kobari, T [1 ]
Miyazawa, T [1 ]
Furukawa, K [1 ]
Miyamoto, T [1 ]
Nagao, K [1 ]
Kanmatsuse, K [1 ]
机构：
[1] Nihon Univ, Surugadai Hosp, Tokyo, Japan
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2003年 / 41卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：296A / 296A
页数：1
相关论文
共 50 条
  • [21] Association of ratios of monocyte/high-density lipoprotein cholesterol and neutrophil/high-density lipoprotein cholesterol with atherosclerotic plaque type on coronary computed tomography
    Okan, Taha
    Topaloglu, Caner
    CARDIOVASCULAR JOURNAL OF AFRICA, 2024,
  • [22] Intensive lipid-lowering therapy, time to think beyond low-density lipoprotein cholesterol
    Abdalwahab, Ahmed
    Al-Atta, Ayman
    Zaman, Azfar
    Alkhalil, Mohammad
    WORLD JOURNAL OF CARDIOLOGY, 2021, 13 (09): : 472 - 482
  • [23] Lipoprotein(a)- and low-density lipoprotein-derived cholesterol in nephrotic syndrome:: Impact on lipid-lowering therapy?
    Kronenberg, F
    Lingenhel, A
    Lhotta, K
    Rantner, B
    Kronenberg, MF
    König, P
    Thiery, J
    Koch, M
    von Eckardstein, A
    Dieplinger, H
    KIDNEY INTERNATIONAL, 2004, 66 (01) : 348 - 354
  • [24] High-density lipoprotein cholesterol associated with change in coronary plaque lipid burden assessed by near infrared spectroscopy
    Honda, Satoshi
    Sidharta, Samuel L.
    Shishikura, Daisuke
    Takata, Kohei
    Di Giovanni, Giuseppe A.
    Nguyen, Tracy
    Janssan, Alex
    Kim, Susan W.
    Andrews, Jordan
    Psaltis, Peter J.
    Worthley, Matthew I.
    Nicholls, Stephen J.
    ATHEROSCLEROSIS, 2017, 265 : 110 - 116
  • [25] HIGH-DENSITY LIPOPROTEIN CHOLESTEROL AS A DETERMINANT OF CHANGE IN CORONARY PLAQUE LIPID BURDEN ASSESSED BY NEAR INFRARED SPECTROSCOPY
    Honda, Satoshi
    Sidharta, Samuel
    Shishikura, Daisuke
    Takata, Kohei
    Andrews, Jordan
    Kim, Susan
    Butters, Julie
    Psaltis, Peter
    Worthley, Matthew
    Nicholls, Stephen
    ATHEROSCLEROSIS, 2017, 263 : E94 - E95
  • [26] Apolipoprotein A-1 predicts coronary heart disease only at low concentrations of high-density lipoprotein cholesterol: an epidemiological study of Japanese-Americans
    Sharp, DS
    Burchfiel, CM
    Rodriguez, BL
    Sharrett, AR
    Sorlie, PD
    Marcovina, SM
    INTERNATIONAL JOURNAL OF CLINICAL & LABORATORY RESEARCH, 2000, 30 (01): : 39 - 48
  • [27] The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders
    Morris, Gerwyn
    Puri, Basant K.
    Bortolasci, Chiara C.
    Carvalho, Andre
    Berk, Michael
    Walder, Ken
    Moreira, Estefania G.
    Maes, Michael
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2021, 125 : 244 - 263
  • [28] Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study
    Colquhoun, D
    Keech, A
    Hunt, D
    Marschner, I
    Simes, J
    Glasziou, P
    White, H
    Barter, P
    Tonkin, A
    EUROPEAN HEART JOURNAL, 2004, 25 (09) : 771 - 777
  • [29] Lipid-Lowering Agents and High HDL (High-Density Lipoprotein) Are Inversely Associated With Intracranial Aneurysm Rupture
    Can, Anil
    Castro, Victor M.
    Dligach, Dmitriy
    Finan, Sean
    Yu, Sheng
    Gainer, Vivian
    Shadick, Nancy A.
    Savova, Guergana
    Murphy, Shawn
    Cai, Tianxi
    Weiss, Scott T.
    Du, Rose
    STROKE, 2018, 49 (05) : 1148 - +
  • [30] Equation-Based Low-Density Lipoprotein Cholesterol Reclassification and Implications For Lipid-Lowering Therapy
    Zheutlin, Alexander R.
    Niforatos, Joshua D.
    Chaitoff, Alexander
    MAYO CLINIC PROCEEDINGS, 2023, 98 (08) : 1258 - 1259
12345